RENB Renovaro
- 1.562
- +0.072+4.84%
Renovaro News
Why Skye Bioscience Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Skye Bioscience, Inc. (NASDAQ:SKYE) fell sharply during Monday's session after the company announced its SBI-100 Ophthalmic Emulsion Phase 2a trial did not achieve target product profile and
12 Health Care Stocks Moving In Monday's Intraday Session
GainersSeres Therapeutics (NASDAQ:MCRB) stock moved upwards by 34.0% to $0.82 during Monday's regular session. The company's market cap stands at $124.5 million. Renovaro (NASDAQ:RENB) shares increase
Express News | Renovaro Shares Resume Trade
Express News | Renovaro Shares Halted On Circuit Breaker To The Upside, Stock Now Up 81.4%
Form 144 | Renovaro(RENB.US) 10% Stockholder Proposes to Sell 398.82K in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 6, $Renovaro(RENB.US)$ 10% Stockholder William Anderson Wittekind intends to sell 275.05K shares of its common stock on Jun 6, with a total market value of approximately $3
American Airlines, Bank OZK, Biohaven Among Premarket Losers' Pack
Express News | Renovaro Inc - Proposed Newco Will Be Headquartered in Amsterdam, Netherlands
Express News | Renovaro Inc - Signed Mou to Establish Joint Company Based in Netherlands Aimed at Pioneering Next Generation of Personalized Cancer Immunotherapy
Express News | Renovaro Inc - Co and Amsterdam Umc Cancer Center Poised to Advance Cancer Immunotherapy
Express News | Renovaro Inc. And Amsterdam UMC Cancer Center Announce Intended Partnership; Sign MoU To Establish Joint Company In The Netherlands For Next-Generation Personalized Cancer Immunotherapy
Renovaro Inc. and Amsterdam UMC Cancer Center Poised to Advance Cancer Immunotherapy
LOS ANGELES and AMSTERDAM, May 24, 2024 (GLOBE NEWSWIRE) -- Renovaro Inc. (NASDAQ:RENB) and the Amsterdam UMC Cancer Center today announced an intended partnership and therefore signed an MoU to establish a joint
Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to $7.4 Billion By 2032
PALM BEACH, Fla., May 24, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - The pancreatic cancer market encompasses the pharmaceutical and healthcare sectors dedicated to addressing the prevention, diagnosis,
12 Health Care Stocks Moving In Thursday's Intraday Session
GainersOneMedNet (NASDAQ:ONMD) shares moved upwards by 118.4% to $1.07 during Thursday's regular session. The market value of their outstanding shares is at $25.5 million. Renovaro (NASDAQ:RENB) stock
Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.The RSI is a momentum indicator, which compares a stock's strength on days when prices go u
Renovaro | 10-Q: Quarterly report
RenovaroCube, Wholly Owned Subsidiary Of Renovaro, Unveils Flamingo, A Multi-Cancer Detection Model Contributing To Its Mission To Transform Early Cancer Diagnostics
RenovaroCube, wholly owned subsidiary of Renovaro, Inc. (NASDAQ:RENB), a company at the forefront of AI-driven healthcare innovation, proudly unveils Flamingo, a potentially groundbreaking multi-cance
Transforming Cancer Detection: RenovaroCube Introduces Flamingo, a Novel AI Model Based on Fragmentomics
LOS ANGELES and AMSTERDAM, April 30, 2024 (GLOBE NEWSWIRE) -- RenovaroCube, wholly owned subsidiary of Renovaro, Inc. (NASDAQ:RENB), a company at the forefront of AI-driven healthcare innovation, proudly unveils
Applied Dna Sciences, OptimizeRx, SCWorx Among Healthcare Movers
Renovaro Amends Binding Letter of Intent To Acquire 100% Ownership of Cyclomics >RENB
Renovaro Amends Binding Letter of Intent To Acquire 100% Ownership of Cyclomics >RENB
Express News | Renovarocube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership
Analysis
Price Target
No Data
